COGT
PTN

Arlene Morris

CIK: 0001362520

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

Cogent Biosciences: Long-term performance review published. Benzinga published an article analyzing the value of a $1,000 investment in Cogent Biosciences made five years ago. This piece focuses on historical returns rather than new corporate developments or immediate market catalysts. The stock is currently trading near its 52-week low, with technical indicators showing recent downward pressure.

this person other insiders at COGT

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

Palatin Reports Q4 2026 Results With Lower Losses. Palatin Technologies released its fiscal year 2026 financial results, reporting a Q4 loss of $1.11 per share, an improvement from the $2.73 loss in the same period last year. The company also reported sales of $300,770 for the quarter. This update provides the latest financial snapshot for the stock, which is currently trading near its 52-week low.

this person other insiders at PTN

Transaction History

COGT▲ Buy$236K
COGT▲ Buy$9K
COGT▼ Sell$119K
COGT▼ Sell$1.6M
PTN▲ Buy$0
PTN▲ Buy$0
PTN▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.